WCLC 2025 - Posters & ePosters-P3.12.21 Biomarker Analysis and Final Efficacy of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer

P3.12.21 Biomarker Analysis and Final Efficacy of Lorlatinib in Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer

Asset Subtitle

Benjamin Solomon

Meta Tag

Speaker Benjamin Solomon

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy